Integrative Clinical Genomics of Advanced Prostate CancerDan R. Robinson, Susana Miranda, Eliezer M. Van Allen et al.|Cell|2015Cited by 3.6k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3Howard I. Scher, Andrew J. Armstrong, Michael J. Morris et al.|Journal of Clinical Oncology|2016Cited by 1.6k
Organoid Cultures Derived from Patients with Advanced Prostate CancerDong Gao, Yu Chen, Ian Vela et al.|Cell|2014Cited by 1.6k
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 studyHoward I. Scher, Charles L. Sawyers, Tomasz M. Beer et al.|The Lancet|2010Cited by 1.1k
Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint BlockadeWassim Abida, Howard I. Scher, Michael L. Cheng et al.|JAMA Oncology|2018Cited by 661